Emergent BioSolutions (EBS) Interest Expenses (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Interest Expenses of $13.1 million for Q1 2026, down 21.56% year-over-year from $16.7 million in Q1 2025, and down 10.88% quarter-over-quarter from $14.7 million in Q4 2025.
Emergent BioSolutions (EBS) Interest Expenses (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Interest Expenses history runs 16 years deep, the most recent figure standing at $13.1 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 21.56% year-over-year to $13.1 million; the TTM figure through Mar 2026 stood at $59.7 million (up 5.85% YoY), while the FY2025 annual figure was $329.6 million, down 2.77% from the prior year.
- Interest Expenses for Q1 2026 stood at $13.1 million, down from $14.7 million in the prior quarter.
- The five-year high for Interest Expenses was $35.0 million in Q2 2025, with the low at $7.8 million in Q2 2022.
- The 5-year median for Interest Expenses is $15.2 million (2025), against an average of $17.0 million.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses jumped 266.67% in 2023, then tumbled 64.06% in 2024.
- Emergent BioSolutions' Interest Expenses stood at $10.6 million in 2022, then soared by 104.72% to $21.7 million in 2023, then sank by 64.06% to $7.8 million in 2024, then surged by 88.46% to $14.7 million in 2025, then decreased by 10.88% to $13.1 million in 2026.
- Business Quant data shows EBS's Interest Expenses at $13.1 million in Q1 2026, $14.7 million in Q4 2025, and $15.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 253.61 Mn | 112.71 Mn | 137.20 Mn | 10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.00 Mn |
| Jun 30, 2026 | 10.00 Mn |
| Mar 31, 2026 | 13.10 Mn |
| Mar 31, 2026 | 13.10 Mn |
| Dec 31, 2025 | 14.70 Mn |
| Dec 31, 2025 | 14.70 Mn |
| Sep 30, 2025 | 15.20 Mn |
| Sep 30, 2025 | 15.20 Mn |
| Jun 30, 2025 | 35.00 Mn |
| Jun 30, 2025 | 35.00 Mn |
| Mar 31, 2025 | 16.70 Mn |
| Mar 31, 2025 | 16.70 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Sep 30, 2024 | 8.30 Mn |
| Sep 30, 2024 | 8.30 Mn |
| Jun 30, 2024 | 23.60 Mn |
| Jun 30, 2024 | 23.60 Mn |
| Mar 31, 2024 | 24.30 Mn |
| Mar 31, 2024 | 24.30 Mn |